Drug reference
teprotumumab
IGF-1 receptor blocker, monoclonal antibody · immunotherapy
IGF-1 receptor blocker, monoclonal antibodyimmunotherapy
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
IGF-1 receptor blocker.
Indications
advanced ophthalmopathy
Drug interactions
12 additional unreviewed or low-confidence interactions hidden because their provenance or source detail is insufficient.
Related guidelines
Ask House about teprotumumab
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Goodman & Gilman 14e·Updated: 2026-05-10